ICER’s approach to reviewing evidence and assessing value is grounded in the core principles of multi-stakeholder engagement and transparency.

How we do our work
ICER’s methods for development of its work, including principles of health technology assessment, topic selection criteria, topic suggestion, evidence rating matrix, and value assessment framework.

Patient, Manufacturer, and Other Stakeholder Engagement
Processes and timelines for producing reports and holding public meetings, and highlights points at which stakeholders are able to offer input into the report development process.

Policies that Guide our Work
Policies that apply to ICER’s employees, collaborators, members of voting bodies, and meeting participants.

Understanding the QALY
The quality-adjusted life year (QALY) is the gold standard for measuring how well all different kinds of medical treatments lengthen and/or improve patients’ lives, and therefore the metric has served as a fundamental component of cost-effectiveness analyses in the US and around the world for more than 30 years.